Alzheimer s Disease Clinical Trials

14 recruiting

Alzheimer s Disease Trials at a Glance

14 actively recruiting trials for alzheimer s disease are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Toronto, Tianjin, and Beijing. Lead sponsors running alzheimer s disease studies include Sunnybrook Health Sciences Centre, Fujian Medical University Union Hospital, and Fu Jen Catholic University.

Browse alzheimer s disease trials by phase

Treatments under study

About Alzheimer s Disease Clinical Trials

Looking for clinical trials for Alzheimer s Disease? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Alzheimer s Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Alzheimer s Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 1

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

HealthyMild Cognitive ImpairmentAlzheimer s Disease
National Institute of Mental Health (NIMH)90 enrolled1 locationNCT07169630
Recruiting
Phase 1

Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

Alzheimer s DiseaseFaecal Microbiota Transplantation (FMT)
University Hospital of North Norway10 enrolled1 locationNCT07332260
Recruiting
Phase 2

Fisetin in Mild Alzheimer's Disease

Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+4 more
Sunnybrook Health Sciences Centre5 enrolled1 locationNCT07279714
Recruiting

Dementia in Fiction and Clinical Narratives

DementiaAlzheimer s Disease
Fu Jen Catholic University40 enrolled1 locationNCT07482800
Recruiting

Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.

Diabete Type 2PARKINSON DISEASE (Disorder)Alzheimer s Disease
Neuromed IRCCS500 enrolled1 locationNCT07467460
Recruiting

VR Pupillometry in Cognitive Impairment

DementiaMajor Depressive Disorder (MDD)Mild Cognitive Impairment+1 more
Max-Planck-Institute of Psychiatry140 enrolled1 locationNCT07402356
Recruiting

Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease

Elderly (People Aged 65 or More)Alzheimer s DiseaseNeurocognition
Hospices Civils de Lyon312 enrolled1 locationNCT07409506
Recruiting
Not Applicable

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

ObesityMetabolic SyndromeInflammation+5 more
University of Seville8 enrolled1 locationNCT07361887
Recruiting
Not Applicable

Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease

Alzheimer s Disease
Fujian Medical University Union Hospital66 enrolled1 locationNCT07324161
Recruiting

[18F]NIDF PET Imaging in Tau-related Diseases

Alzheimer s DiseaseTauopathiesNeurodegenerative Disease
Tianjin Medical University20 enrolled2 locationsNCT07306598
Recruiting
Phase 2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+3 more
Sunnybrook Health Sciences Centre12 enrolled1 locationNCT07279740
Recruiting
Not Applicable

Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition

Insulin SensitivityAlzheimer s DiseaseAlzheimer Blood Biomarkers
Pennington Biomedical Research Center8 enrolled1 locationNCT07265323
Recruiting
Phase 3

Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)

Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd.320 enrolled23 locationsNCT07262645
Recruiting

Predictors of Emergency Department Use in Frail Patients

ElderlyFrailtyAlzheimer s Disease+3 more
University of Pisa110 enrolled1 locationNCT07259499